Evidence map›Paper›PMID 36447816›Full record

ArticleVirusdisease2022

Lifestyle, Epstein-Barr virus infection, and other factors could impede nasopharyngeal cancer survivorship: a five-year cross-sectional study in North Eastern India.

Koustav Chatterjee, Sankar Deb Roy, Koushik Chakraborty, Asmaul Haque, Sudipta Chakrabarti, Syamantak Mukherjee, Sudipa Mal, Nilanjana Das, Sushil Kumar Sahu, Nabanita Roy Chattopadhyay and 17 more

Open access · greenAbstract read
In one paragraph

Article in Virusdisease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 1 country.

Koustav ChatterjeeDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Sankar Deb RoyDepartment of Radiation Oncology, Eden Medical Center, Dimapur, Nagaland India.
Koushik ChakrabortyDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Asmaul HaqueDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Sudipta ChakrabartiMidnapore City College, Paschim Medinipur, Kuturia, Bhadutala, West Bengal India.
Syamantak MukherjeeDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Sudipa MalDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Nilanjana DasDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Sushil Kumar SahuDepartment of zoology, Visva-Bharati, Santiniketan, West Bengal India.
Nabanita Roy ChattopadhyayDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
Piyanki DasDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.
R Rajendra ReddyClinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
Moatoshi AierDepartment of pathology, Eden Medical Center, Dimapur, Nagaland India.
Ashok Kumar DasDepartment of Head & Neck Oncology, Dr. Bhubaneswar Borooah Cancer Institute, Guwahati, Assam India.
Nizara BaishyaDepartment of Head & Neck Oncology, Dr. Bhubaneswar Borooah Cancer Institute, Guwahati, Assam India.
R Ravi KannanCachar Cancer Hospital and Research Centre. N. S. Avenue, Meherpur, Silchar, Assam India.
Zoreng PuiiState Referral Hospital, Falkawn, Mizoram India.
Eric ZomawiaState Referral Hospital, Falkawn, Mizoram India.
Yengkhom Indibor SinghDepartment of Radiotherapy, Regional Institute of Medical Sciences, Imphal, Manipur India.
Sam TseringTertiary cancer center, TomoRiba Institute Of Health, and Medical Sciences, Naharlagun, Arunachal Pradesh India.
Komri RibaTertiary cancer center, TomoRiba Institute Of Health, and Medical Sciences, Naharlagun, Arunachal Pradesh India.
Shanmugam RajasubramaniamDivision of Genetic Disorders, ICMR-National Institute of Research in Tribal Health, NIRTH Complex, Jabalpur, Madhya Pradesh India.
Bhabani Sankar DasClinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
Amol Ratnakar SuryawanshiClinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
Arindom ChakrabortyDepartment of Statistics, Visva-Bharati, Santiniketan, West Bengal India.
Sandeep GhatakDivision of Animal and Fishery Science, ICAR Research Complex for North East Hill Region, Umiam, Meghalaya India.
Tathagata ChoudhuriDepartment of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal India.ORCID 0000-0003-4022-0318
Visva-Bharati University · INInstitute of Life Sciences · INBhubaneswar Borooah Cancer Institute · INChristian Hospital Serkawn · INNational Institute of Technology Arunachal Pradesh · INChristian Institute of Health Sciences and Research Hospital · INGovernment Medical College · INICAR Research Complex for NEH Region · INMidnapore Medical College and Hospital · INNational Institute for Research in Tribal Health · INRegional Institute of Medical Sciences · INSilchar Medical College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal Carcinoma (NPC) is one of the leading cancers in India's north-eastern (NE) region affecting a section of the population each year. A proportion of the NPC cases are observed to recur even after therapy, indicating the involvement of other factors. We aimed to explore the NPC and Epstein-Barr virus (EBV) burden in the NE region and investigate the prognostic factors for the NPC patients' poor survival and recurrence. NPC patients' information was obtained from different state hospitals between 2014 and 2019. PCR and Sanger sequencing were performed to detect EBV types. Statistical analysis, including forest plot analysis, Kaplan-Mayer survival plot, Log-rank test, cox hazard regression, and Aalen's additive regression model, were performed to determine prognostic factors for the NPC patients' lower survival and recurrence. We observed an increased incidence of NPC and EBV infection in the past five years. Step-wise statistical analyses pointed out that variable such as non-professionals (B = 1.02, HR = 2.8, 95%CI = 1.5,4.9) workers (B = 0.92, HR = 2.5, 95%CI = 1.4,4.4), kitchen cum bedroom (B = 0.61, HR = 1.8, 95%CI = 1.2,2.8), mosquito repellent (B = 0.60, HR = 1.7, 95%CI = 1.1,2.7), nasal congestion (B = 0.60, HR = 1.8, 95%CI = 1.2,2.8), lower haemoglobin level (B = 0.92, HR = 2.5, 95%CI = 1.3,4.9), tumor stage IV (B = 2.8, HR = 1.8, 95%CI = 1.6,14.3), N2 (B = 1.4, HR = 4.0, 95%CI = 1.8,9.1), N3 (B = 1.9, HR = 6.4, 95%CI = 2.8,15.3), and M+ (B = 2.02, HR = 7.5, 95%CI = 4.1,13.7) revealed significant correlation with NPC patients' poor prognosis (p < 0.05). The presence of viral factors also showed a significant association with NPC patients' decreased survival. We concluded that factors related to day-to-day life with EBV infection could be the individual predictor for NPC incidence, lower survival, and disease recurrence. Supplementary Information: The online version contains supplementary material available at 10.1007/s13337-022-00789-5.

Indexed as

EBVNasopharyngeal carcinomaPublic healthRisk factorsSurvivalSurvivorship

Identifiers

PMID36447816
PMCPMC9701304
OpenAlexW4308515690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.